The MAVORIC trial included a broad range of patients^3,24

Blood classification^4,5,25

Key exclusion criteria⁴

• Large cell transformation at study entry
• Active autoimmune diseases
• CNS metastasis
• Active infection requiring therapy
• Medical conditions requiring initiation of systemic corticosteroids or other immunosuppressive medication